Bulk Manufacturer of Controlled Substances Application: AUSTIN PHARMA, LLC, 32322 [2014-12944]
Download as PDF
<![CDATA[
32322
Federal Register / Vol. 79, No. 107 / Wednesday, June 4, 2014 / Notices
substances to make reference standards
for distribution to their customers.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–12972 Filed 6–3–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR part 0,
subpart R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on March
27, 2014, Austin Pharma, LLC., 811
Paloma Drive, Suite C, Round Rock,
Texas 78665–2402, applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
Drug Enforcement Administration
Controlled substance
Schedule
[Docket No. DEA–392]
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Bulk Manufacturer of Controlled
Substances Application: AUSTIN
PHARMA, LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before August 4, 2014.
ADDRESSES: Written comments should
be to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
DATES:
I
I
The company plans to manufacture
bulk synthetic active pharmaceutical
ingredients (APIs) for distribution and
new product development to its
customers. The company plans to bulk
manufacture a synthetic
tetrahydrocannabinol.
In reference to drug code 7360, the
company plans to manufacture a
synthetic cannabinol in bulk for sale to
its customers. The controlled substance
will be further synthesized to bulk
manufacture a synthetic
tetrahydrocannabinol (7370). No other
activity for this drug code is authorized
for this registration.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–12944 Filed 6–3–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: Cayman
Chemical Company
ACTION:
Cayman Chemical Company
applied to be registered as a
manufacturer of certain basic classes of
narcotic or non-narcotic controlled
substances. The DEA grants Cayman
Chemical Company registration as a
manufacturer of those controlled
substances.
SUMMARY:
By notice
dated December 31, 2013, and
published in the Federal Register on
January 10, 2014, 79 FR 1889, Cayman
Chemical Company, 1180 East Ellsworth
Road, Ann Arbor, Michigan 48108,
applied to be registered as a
manufacturer of certain basic classes of
narcotic or non-narcotic controlled
substances.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823(a) and
determined that the registration of
Cayman Chemical Company to
manufacture the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verified the
company’s compliance with state and
local laws, and reviewed the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the basic classes of
narcotic or non-narcotic controlled
substances listed:
SUPPLEMENTARY INFORMATION:
Notice of registration.
tkelley on DSK3SPTVN1PROD with NOTICES
Controlled substance
Schedule
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
4-Methyl-N-methylcathinone (1248) ............................................................................................................................................................
N-Ethylamphetamine (1475) ........................................................................................................................................................................
N,N-Dimethylamphetamine (1480) ..............................................................................................................................................................
Aminorex (1585) ..........................................................................................................................................................................................
4-Methylaminorex (cis isomer) (1590) .........................................................................................................................................................
Gamma Hydroxybutyric Acid (2010) ...........................................................................................................................................................
JWH-250 (6250) ..........................................................................................................................................................................................
SR-18 also known as RCS-8 (7008) ...........................................................................................................................................................
XLR11 (7011) ..............................................................................................................................................................................................
JWH-019 (7019) ..........................................................................................................................................................................................
AKB48 (7048) ..............................................................................................................................................................................................
JWH-081 (7081) ..........................................................................................................................................................................................
SR-19 also known as RCS-4 (7104) ...........................................................................................................................................................
1-Pentyl-3-(1-naphthoyl)indole (7118) .........................................................................................................................................................
JWH-122 (7122) ..........................................................................................................................................................................................
VerDate Mar<15>2010
16:05 Jun 03, 2014
Jkt 232001
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
E:\FR\FM\04JNN1.SGM
04JNN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 79, Number 107 (Wednesday, June 4, 2014)]
[Notices]
[Page 32322]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-12944]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: AUSTIN
PHARMA, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before August 4, 2014.
ADDRESSES: Written comments should be to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, and dispensers of controlled substances
(other than final orders in connection with suspension, denial, or
revocation of registration) has been redelegated to the Deputy
Assistant Administrator of the DEA Office of Diversion Control
(``Deputy Assistant Administrator'') pursuant to sec. 7(g) of 28 CFR
part 0, subpart R, App.
In accordance with 21 CFR 1301.33(a), this is notice that on March
27, 2014, Austin Pharma, LLC., 811 Paloma Drive, Suite C, Round Rock,
Texas 78665-2402, applied to be registered as a bulk manufacturer of
the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
------------------------------------------------------------------------
The company plans to manufacture bulk synthetic active
pharmaceutical ingredients (APIs) for distribution and new product
development to its customers. The company plans to bulk manufacture a
synthetic tetrahydrocannabinol.
In reference to drug code 7360, the company plans to manufacture a
synthetic cannabinol in bulk for sale to its customers. The controlled
substance will be further synthesized to bulk manufacture a synthetic
tetrahydrocannabinol (7370). No other activity for this drug code is
authorized for this registration.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-12944 Filed 6-3-14; 8:45 am]
BILLING CODE 4410-09-P
